April 20, 2024 4:20 am
More Japanese individuals hospitalized due to red yeast rice consumption

On April 1, health authorities in Taiwan reported 11 cases of health problems linked to Kobayashi’s beni koji, with one individual purchasing the product in Japan. This came after the Japanese Ministry of Health reported that an additional 9 people were hospitalized after using the product from pharmaceutical company Kobayashi, bringing the total number of patients to 166. The health status of these 9 patients is currently unknown. Most of the previously hospitalized individuals experienced symptoms such as irritability, loss of appetite, abnormal urine, and kidney disorders.

Kobayashi introduced the product “beni-koji choleste help” in February 2021 and sold approximately one million packs by the end of February this year. Many users later developed kidney disease. The company identified puberulic acid, a natural compound derived from green mold, in the production of beni-koji, which was stated to be a potent antibacterial and antimalarial substance that can be toxic to users. However, it was not approved for circulation in Vietnam and individuals are warned against purchasing it through social networks. If these products are found in the market, individuals are urged to notify authorities for appropriate action in accordance with the law.

Leave a Reply